ArticleFrontiers in surgery2026
Aortic dissection precipitated by superwarfarin (brodifacoum) poisoning: a case report and pathophysiological review.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Poisoning by rodenticides, particularly anticoagulant agents, has been well-documented. Brodifacoum, a second-generation "superwarfarin", is a long-acting anticoagulant rodenticide (LAAR) characterized by an extended half-life. Its toxicity primarily manifests as excessive or abnormal bleeding from the skin, mucous membranes, gastrointestinal tract, and urinary tract. However, aortic dissection (AD)-a rare and catastrophic medical event-has seldom been reported as a complication of such poisoning. We present a case of extensive aortic dissection triggered by Brodifacoum poisoning. This case aims to elucidate the potential pathophysiological link between superwarfarin intoxication and the development of aortic dissection. Case presentation: A 69-year-old man was admitted to the hospital with a 9-day history of oral bleeding and an 8-day history of pain in the lower back, abdomen, and chest. Initial examinations at another facility were inconclusive. Upon transfer to our hospital, computed tomography angiography (CTA) revealed an extensive aortic dissection extending from the distal abdominal aorta to the bilateral iliac arteries. Key coagulation tests on admission indicated severe coagulopathy: both prothrombin time (PT) and the international normalized ratio (INR) were undetectable, and the activated partial thromboplastin time (APTT) was markedly prolonged to 160.1 s. Concurrent hematological tests revealed anemia (hemoglobin 102 g/L). Toxicological screening confirmed the presence of Brodifacoum in his blood. The patient's condition was stabilized through aggressive management, including infusion of fresh frozen plasma (FFP), high-dose intravenous vitamin K, and strict blood pressure control. His coagulation parameters gradually normalized over two weeks. Conclusion: This case highlights a life-threatening complication of superwarfarin poisoning-aortic dissection. It underscores the critical importance of considering toxicological etiologies in patients with unexplained coagulopathy. Early reversal of the coagulation deficit and rigorous blood pressure control are paramount in preventing the progression of dissection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.